Leigh MacMillan

Large-scale integration of genomics, proteomics and clinical records identifies cancer risk proteins and potential therapeutics

A new study identifies previously unreported protein biomarkers and candidate drug targets across six major cancer types and highlights approved drugs with potential cancer preventive effects.

Inflammatory marker could predict response to therapy in bladder pain syndrome

Patients with chronic bladder pain syndrome who had higher baseline levels of the inflammatory molecule IL-1beta had greater overall improvement following cognitive behavioral therapy.

Prescribing with purpose

A Vanderbilt University Medical Center study finds unnecessary antibiotic prescriptions in hospitalized children and highlights opportunity for antibiotic stewardship.

Collaborative forms to better predict, prevent and treat Type 1 diabetes

The new project will map Type 1 diabetes progression using multimodal artificial intelligence alongside a wide range of health data.

New NCI-funded project targets polyp recurrence to prevent colon cancer

The researchers anticipate that their findings will inform personalized colorectal polyp surveillance, guide therapeutic prevention strategies, and ultimately reduce the burden of colorectal cancer nationwide.

By Leigh MacMillan

October 9, 2025

Mariana Byndloss honored by microbiology society

Byndloss, who joined the Vanderbilt faculty in 2018, studies the links between the gut microbiota (the microorganisms that reside in the intestines), host metabolism and disease.